The effectiveness of multi-disciplinary pain management and motivational interviewing for people with chronic pai
- Conditions
- Chronic musculoskeletal painMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12622000829718
- Lead Sponsor
- a Trobe University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 184
On completion of baseline assessment, physiotherapists will discuss participation in the trial if participants meet the following inclusion criteria:
i.have a primary complaint of chronic musculoskeletal pain (of greater than 3 months duration)
ii.are presumed to have a pain type of nociplastic dominant pain;
iii.were referred for a multidisciplinary pain management program;
iv.are aged between 18 and 75 years;
v.have sufficient fluency in English to complete all baseline and follow up questionnaires;
vi.have a Pain Disability Questionnaire score measure of disability of at least 50/150; and a Numerical Pain Rating Scale score of at least 3/10, to ensure that Pain Management was indicated and that there was sufficient scope for improvement to be demonstrated.
Participants will not be approached for consent if any of the following exclusion criteria are met, but reasons for exclusion will be recorded:
i.red flag pathologies unsuitable for pain management (active cancer, signs of cauda equina syndrome based on bladder or bowel disturbance, risk of spinal fracture, signs of potential infection, systemic inflammatory disease
ii.chronic cancer, pelvic or neuropathic (eg post herpatic neuralgia) pain;
iii.recent or pending surgery for the pain condition;
iv.pregnancy or childbirth within the last 6 months;
v.injections for the pain problem within the last 6 weeks, as we wish to study treatment effects independent to the effects of such procedures;
vi.have already received multi-disciplinary pain management for the main pain problem within the last 2 years, to avoid contamination.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain self-efficacy questionniare[ 52-weeks post randomisation];Pain interference on the Brief Pain Inventory[ 52-weeks post randomisation]
- Secondary Outcome Measures
Name Time Method